Checkpoint Therapeutics Inc (NASDAQ:CKPT)

3.31
Delayed Data
As of Oct 15
 -0.07 / -2.06%
Today’s Change
2.16
Today|||52-Week Range
5.38
+24.91%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 17.00, with a high estimate of 20.00 and a low estimate of 8.00. The median estimate represents a +413.60% increase from the last price of 3.31.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

Chart unavailable

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$114.0K
Reporting Date
Nov 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.33%
 
 
 
 
 
 
Growthannually -23.90%
 
 
 
 
 
 

Sales

Growthquarterly -26.45%
 
 
 
 
 
 
Growthannually -52.37%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.